Brian C Stephenson bought $326k of FTH
Chief Financial Officer at Sensei Biotherapeutics, Inc.. 13,634 shares at an average of $23.92, traded Jun 29, 2026, filed Jul 1, 2026.
Score components
- +22RoleCFO
- +15Trade size$326k at market
- +6Relative to holdingsHoldings up 41%
- +8Price context34% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001780030-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | POpen-market purchase Common Stockindirect: See footnote | +831 | $23.34 | $19k | 33,885 | Jul 1, 2026 |
| Jun 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,910 | $22.95 | $44k | 35,795 | Jul 1, 2026 |
| Jun 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +1,638 | $23.88 | $39k | 37,433 | Jul 1, 2026 |
| Jun 30, 2026 | POpen-market purchase Common Stockindirect: See footnote | +4,255 | $24.98 | $106k | 41,688 | Jul 1, 2026 |
| Jul 1, 2026 | POpen-market purchase Common Stockindirect: See footnote | +4,400 | $23.40 | $103k | 46,088 | Jul 1, 2026 |
| Jul 1, 2026 | POpen-market purchase Common Stockindirect: See footnote | +600 | $24.22 | $15k | 46,688 | Jul 1, 2026 |
Related signals
Other insiders at Sensei Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 69Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $401k 15,641 shares | +90% | |
| 62Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $406k 17,413 shares | - | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Anand Kiran Parikh President and CEO | $55k 2,806 shares | +0% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc owner | $501k 25,000 shares | -16% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | James Peyer owner, other | $501k 25,000 shares | -16% | |
| 39Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $818k 30,585 shares | +23% | |
| 21Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $89k 3,250 shares | -2% | |
| 31Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $382k 12,180 shares | +8% | |
| 20Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $77k 2,741 shares | -2% | |
| 23Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $141k 4,215 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.